abnormal response/metabolism to endogenous compounds_Tnfrsf1a<tm1Blt>/Tnfrsf1a<+>

http://metadb.riken.jp/0003638I129P2OlaHsdTnfrsf1atm1BltTnfrsf1aTnfrsf1atm1BltTnfrsf1a

abnormal response/metabolism to endogenous compounds_Tnfrsf1a<tm1Blt>/Tnfrsf1a<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• tumor necrosis factor receptor superfamily, member 1a
  http://metadb.riken.jp/db/mgi_rdf/MGI:1314884

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tnfrsf1a<tm1Blt>/Tnfrsf1a<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tnfrsf1a<tm1Blt>|Tnfrsf1a<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal response/metabolism to endogenous compounds
  http://purl.obolibrary.org/obo/MP_0003638

文献

http://purl.org/net/cito/citesAsAuthority

• Filip. Van Hauwermeiren, et.al., Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium., The Journal of clinical investigation, 2013, 123
  http://rdf.ncbi.nlm.nih.gov/pubmed/23676465